Reporting on GLP-1s and eating disorders

A few years after drugs like Ozempic and Wegovy hit the mainstream, stories about their widespread use and unexpected consequences (for better and worse) continue to capture readers’ and editors’ attention. What angles still need to be explored, particularly when it comes to how the meds might both exacerbate and quell eating disorder symptoms? What do mental health professionals and obesity medicine specialists think journalists have gotten wrong or have overlooked?

In partnership with Equip, AHCJ New York invites you to an intimate panel discussion featuring Equip co-founder and clinical psychologist Erin Parks, Bea Better Eating co-founder and clinical psychologist Sera Lavelle, and likely one physician with relevant expertise. Anna Medaris, who’s covered everything from GLP-1s’ promise in addiction medicine to their infiltration in the running community and their psychological implications, will moderate. Refreshments will be served.

RSVP by emailing Anna Medaris at the link below before Sept. 23 to ensure entry.